M. Nagy

Taha, A., Nagy, M., Hund, H. M., van Doormaal, P. J., van Noorden, K., Spronk, H. M. H., Ceulemans, A., van Oostenbrugge, R. J., Duncker, D. J., ten Cate, H., Dippel, D., van Es, A. C. G. M., Bobi, J., & van Beusekom, H. M. M. (2025). Vascular injury and occurrence of microthrombi after endovascular therapy for acute ischaemic stroke in a thromboembolic model. BMJ Neurology Open, 7(1), Article e000989. https://doi.org/10.1136/bmjno-2024-000989

Ceulemans, A., Barakzie, A., Spronk, H. M. H., de Maat, M. P. M., van Beusekom, H. M. M., Taha, A., Emmer, B. J., Roos, Y. B. W. E. M., Dippel, D. W. J., Majoie, C. B. L. M., van Zwam, W. H., ten Cate, H., van Oostenbrugge, R. J., & Nagy, M. (2025). Association between coagulation activity and clinical and imaging outcomes in acute ischemic stroke patients - A sub-study of the MR CLEAN NO-IV trial. Thrombosis Research, 245, Article 109212. https://doi.org/10.1016/j.thromres.2024.109212

van Mourik, D. J. M., Jansen, V. L. B. I., Coppens, M., Middeldorp, S., ten Cate, H., Buller, H. R., Spronk, H. M. H., Nagy, M., & van Mens, T. E. (2025). Intrinsic pathway activation in patients with antiphospholipid syndrome and healthy controls. Research and practice in thrombosis and haemostasis, 9(1), Article 102694. https://doi.org/10.1016/j.rpth.2025.102694

Barakzie, A., Jansen, G. A. J., Cavalcante, F., Nagy, M., Dippel, D. W. J., van der Lugt, A., Roos, Y. B. W. E. M., Majoie, C. B. L. M., Cate, H. T., de Maat, M. P. M., & CONTRAST Consortium (2025). Association of primary and secondary hemostasis biomarkers with acute ischemic stroke outcome in patients undergoing thrombectomy, with or without thrombolytics: post hoc analysis of the Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands-NO IV. Journal of Thrombosis and Haemostasis, 23(1), 235-247. https://doi.org/10.1016/j.jtha.2024.10.008

Gomez-Rosas, P., Nagy, M., Spronk, H. M. H., Russo, L., Gamba, S., Tartari, C. J., Bolognini, S., Ticozzi, C., Schieppati, F., Sarmiento, R., De Braud, F., Masci, G., Tondini, C., Petrelli, F., Giuliani, F., D'Alessio, A., Santoro, A., Gasparini, G., Labianca, R., ... HYPERCAN Investigators (2025). Activated FXI-antithrombin and thrombin-antithrombin complexes in the prediction of venous thromboembolism and mortality in non-small cell lung cancer patients. Journal of Thrombosis and Haemostasis. Advance online publication. https://doi.org/10.1016/j.jtha.2025.02.029

Hansildaar, R., Raadsen, R., Gerritsen, M., Nagy, M., Dijkshoorn, B., Spronk, H. M. H., Ten Cate, H., & Nurmohamed, M. T. (2024). Comparative Analysis of Coagulation Activation in Rheumatoid Arthritis Patients Treated With TNF Inhibitors Versus JAK Inhibitors: A Longitudinal Study. Journal of Clinical Rheumatology, 30(8), e166-e171. Article 002136. https://doi.org/10.1097/RHU.0000000000002136

Baaten, C. C. F. M. J., Nagy, M., Spronk, H. M. H., Ten Cate, H., & Kietselaer, B. L. J. H. (2024). NETosis in Cardiovascular Disease: An Opportunity for Personalized Antithrombotic Treatments? Arteriosclerosis Thrombosis and Vascular Biology, 44(12), 2366-2370. https://doi.org/10.1161/ATVBAHA.124.320150

Ceulemans, A., Spronk, H. M. H., Ten Cate, H., van Zwam, W. H., van Oostenbrugge, R. J., & Nagy, M. (2024). Current and potentially novel antithrombotic treatment in acute ischemic stroke. Thrombosis Research, 236, 74-84. https://doi.org/10.1016/j.thromres.2024.02.009

Busch, M. H., Ysermans, R., Aendekerk, J., Timmermans, S. A., Potjewijd, J., Damoiseaux, J., Spronk, H. M. H., Ten Cate, H., Reutelingsperger, C., Nagy, M., & van Paassen, P. (2024). The intrinsic coagulation pathway plays a dominant role in driving hypercoagulability in ANCA-Associated Vasculitis. Blood advances, 8(5), 1295-1304. https://doi.org/10.1182/bloodadvances.2023011937

Baaten, C. C. F. M. J., Nagy, M., Bergmeier, W., Spronk, H. M. H., & van der Meijden, P. E. J. (2024). Platelet biology and function: plaque erosion vs. rupture. European Heart Journal, 45(1), 18-31. https://doi.org/10.1093/eurheartj/ehad720